Introduction
In less than three years, a novel form of acquired immunodeficiency has been newly described, its epidemiology established, the characteristic immunopathology defined, and the etiologic agent identified. The acquired immunodeficiency syndrome, better known by its acronym AIDS,' is a spectrum of abnormalities ranging from the full-blown form in patients with opportunistic infections and certain bizarre malignancies to a more benign form in patients with lymphadenopathy and fever. All groups have a characteristic immunological abnormality that will be discussed below. AIDS has been recognized almost exclusively in certain "at risk" groups, so much so that the diagnosis is almost certainly excluded in patients from groups not "at risk." Over 70% of the cases have been reported in homosexually active males (1) (2) (3) . The second largest group of patients have been intravenous drug abusers (4) . The syndrome has been diagnosed in hemophiliacs receiving Factor VIII concentrates and in other recipients of blood products or whole blood (5) (6) (7) (8) (9) . Gamma globulin (immune serum globulin) has not, however, been incriminated in the transmission of AIDS. Infants born to mothers in the aforementioned risk groups have developed the syndrome even when separated from their mothers at birth (10, 1 1).
AIDS has been diagnosed among Haitian immigrants in the United States and among individuals from Zaire who reside in Belgium and France (12, 13) . This has led to the recognition of the fact that there is probably a large reservoir of AIDS, or at least its causative agent, in the Caribbean and in Central Africa. The (17) . An etiologic nexus between the AIDS agent and Kaposi's sarcoma may prove to be as complex as that between Epstein-Barr virus and Burkitt's lymphoma. In any event, the mortality rate in patients with opportunistic infections with or without Kaposi's sarcoma is extremely high and survival from onset of the full-blown syndrome to death rarely exceeds a year or two.
A more mild version of the syndrome has been recognized among risk groups and has been called pre-AIDS or AIDSrelated syndrome. It consists of persistent lymphadenopathy, night sweats, fever, and weight loss (18) . Only a small proportion of patients, perhaps 10%, with the prodrome progress to the full-blown syndrome. Yet, the full-blown form of AIDS may occur without a prodromal stage.
The characteristic immunologic abnormality is in some degree common to these various groups of patients and has been observed in totally asymptomatic individuals in high risk groups (19 (26, 27) . Therein must reside the functional importance of the T4 and T8 antigens on T lymphocytes. The previously held view that these antigenic markers neatly divided "helper" from "suppressor" T cells is no longer tenable and this awareness clarifies many of the old paradoxes that used to befuddle attempts to explain inconsistencies in the interpretation of the immunopathology of AIDS.
There are a number of immunologic consequences of the aforementioned events in AIDS that remain to be explained. Down-regulation of Ia (MHC class II) antigens is observed in cells of monocyte lineage (28) . Elevated levels of circulating immune complexes are found together with increased circulating antilymphocyte antibodies, soluble suppressor factors, acid-labile a-interferon, #2 microglobulin, and a, thymosine (29) (30) (31) . At present, to make an educated guess, it seems likely that these are all secondary events.
Etiologic considerations
As previously mentioned, two groups of investigators have identified a lymphocytotropic retrovirus from blood and node lymphocytes of patients with full-blown AIDS or of patients with the prodromal manifestations. The Pasteur group calls their agent LAV for lymphadenopathy virus whereas the Bethesda workers have designated the agent human T cell leukemia virus III (HTLV III) (14, 15) . It is similar to but distinct from HTLV I and II. Seropositivity has been found in a very high proportion of all risk groups. It has been possible to propagate the virus in transformed human neoplastic T cells. There is some cross-reactivity of antibody to the envelope proteins of HTLV I and HTLV III and this probably caused confusion early on when some 40% of AIDS patients were found to have antibody to HTLV I. It seems that the development of successful therapeutic or vaccination strategies will now depend to a greater extent on our understanding of the cytopathic mechanisms of these agents and their effects on the immune response.
Relationship to other immunodeficiency diseases Lymphocytotropic viruses have been known to cause immunodeficiency in animal models. A form of AIDS has been observed in macaque monkeys. Simian AIDS is characterized not only by opportunistic infections but is also different from the human form by the occurrence of profound neutropenia and lymphopenia and hypogammaglobulinemia. A type D lymphocytotropic retrovirus has been isolated from affected monkeys (32) .
For many years, a lymphocytotropic retrovirus has been known to cause feline leukemia. The feline leukemia virus causes immunosuppression in cats and renders them exquisitely susceptible to opportunistic infections. This susceptibility in cats is a more common outcome from feline leukemia virus infection than leukemia itself (33) .
Measles virus in man is known to infect the cellular elements of the immune system. Anergy is a well-known complication of measles infection but the mechanism of this anergy is not well understood. Infectious mononucleosis has been better studied in this regard. Epstein-Barr virus gives rise to a period of self-limited immunosuppression by activation of the T cell suppressor network (34 
